2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors.

Tytuł:: 2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors.
Autorzy:: Meyer MT; Department of Otorhinolaryngology, Head and Neck Surgery, University of Giessen, Klinikstrasse 33, Ebene -1, 35392 Giessen, Germany.
Watermann C; Department of Otorhinolaryngology, Head and Neck Surgery, University of Giessen, Klinikstrasse 33, Ebene -1, 35392 Giessen, Germany.
Dreyer T; Institute for Pathology, Justus Liebig University, Langhansstrasse 10, 35392 Gießen, Germany.
Ergün S; Institute for Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Koellikerstrasse 6, 97070 Würzburg, Germany.
Karnati S; Institute for Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Koellikerstrasse 6, 97070 Würzburg, Germany.
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Jun 24; Vol. 22 (13). Date of Electronic Publication: 2021 Jun 24.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:: Biomarkers, Tumor*
Genetic Predisposition to Disease*
Genetic Testing*/methods
Genetic Testing*/standards
Translocation, Genetic*
Salivary Gland Neoplasms/*diagnosis
Salivary Gland Neoplasms/*genetics
Genetic Association Studies ; Humans ; Neoplasm Grading ; Neoplasm Staging ; Preoperative Care/methods ; Preoperative Care/standards ; Salivary Gland Neoplasms/metabolism ; Salivary Gland Neoplasms/therapy
References:: Am J Clin Pathol. 2015 Jun;143(6):839-53. (PMID: 25972326)
Am J Surg Pathol. 2011 Jan;35(1):92-9. (PMID: 21164292)
Auris Nasus Larynx. 2004 Mar;31(1):49-55. (PMID: 15041054)
Virchows Arch. 2011 May;458(5):583-92. (PMID: 21394649)
J Clin Diagn Res. 2017 May;11(5):ER04-ER06. (PMID: 28658793)
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May;95(5):586-93. (PMID: 12738950)
HNO. 1976 Dec;24(12):415-26. (PMID: 1002574)
Mod Pathol. 2012 Jul;25(7):919-29. (PMID: 22460810)
Head Neck. 2005 Aug;27(8):696-702. (PMID: 16021638)
Histopathology. 2016 Apr;68(5):641-7. (PMID: 26212680)
Am J Clin Pathol. 2011 Nov;136(5):729-38. (PMID: 22031311)
Mod Pathol. 2003 Dec;16(12):1224-31. (PMID: 14681323)
J Histochem Cytochem. 1988 May;36(5):487-91. (PMID: 2451689)
Neuroimaging Clin N Am. 2018 May;28(2):303-317. (PMID: 29622121)
Dis Markers. 2011;30(5):229-33. (PMID: 21734342)
Diagn Pathol. 2011 Sep 26;6:89. (PMID: 21943228)
Head Neck Pathol. 2014 Jun;8(2):133-40. (PMID: 24065449)
Cancer Cytopathol. 2016 Jun;124(6):397-405. (PMID: 26882287)
Anticancer Res. 2000 Mar-Apr;20(2B):1205-11. (PMID: 10810423)
Am J Surg Pathol. 2005 Jun;29(6):806-13. (PMID: 15897748)
Virchows Arch. 2006 Dec;449(6):660-6. (PMID: 17091257)
J Cytol. 2018 Jan-Mar;35(1):57-59. (PMID: 29403174)
CA Cancer J Clin. 2000 May-Jun;50(3):171-83. (PMID: 10901740)
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):495-500. (PMID: 16997117)
Oncogene. 2006 Sep 14;25(41):5626-39. (PMID: 16636670)
Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):203-9. (PMID: 10981872)
J Clin Med. 2020 Apr 18;9(4):. (PMID: 32325647)
Oral Dis. 2008 Oct;14(7):613-9. (PMID: 18221458)
Eur Arch Otorhinolaryngol. 2014 Jul;271(7):1999-2007. (PMID: 24091559)
Oral Oncol. 2008 Jun;44(6):563-70. (PMID: 17936671)
Arch Otolaryngol Head Neck Surg. 2004 Feb;130(2):174-80. (PMID: 14967746)
Med Oral Patol Oral Cir Bucal. 2020 Jul 1;25(4):e516-e522. (PMID: 32388524)
Curr Opin Otolaryngol Head Neck Surg. 2005 Apr;13(2):123-6. (PMID: 15761289)
Mod Pathol. 2013 Aug;26(8):1041-50. (PMID: 23558573)
Arch Pathol Lab Med. 2015 Jan;139(1):55-66. (PMID: 25549144)
Ann Diagn Pathol. 2009 Oct;13(5):313-21. (PMID: 19751908)
Br J Oral Maxillofac Surg. 2013 Jul;51(5):399-403. (PMID: 23103239)
Diagn Cytopathol. 2006 Nov;34(11):734-8. (PMID: 17041956)
Am J Clin Pathol. 2011 Jul;136(1):45-59. (PMID: 21685031)
Ear Nose Throat J. 2017 Mar;96(3):E13-E16. (PMID: 28346649)
Virchows Arch. 2002 May;440(5):536-42. (PMID: 12021929)
Am J Surg Pathol. 2010 Aug;34(8):1106-21. (PMID: 20588178)
J Pathol. 1985 May;146(1):51-8. (PMID: 4009321)
Head Neck Pathol. 2007 Sep;1(1):27-32. (PMID: 20614277)
Oral Oncol. 2005 Jan;41(1):3-10. (PMID: 15598579)
Adv Anat Pathol. 2013 Nov;20(6):367-77. (PMID: 24113307)
Head Neck Pathol. 2017 Mar;11(1):55-67. (PMID: 28247227)
Acta Histochem Cytochem. 2012 Oct 31;45(5):269-82. (PMID: 23209336)
Br J Oral Maxillofac Surg. 2008 Dec;46(8):635-8. (PMID: 18620785)
Contributed Indexing:: Keywords: adenoid cystic carcinoma (ACC); diagnostic markers; epithelial salivary gland; mucoepidermoid carcinoma; pleomorphic adenoma; salivary gland tumors
Substance Nomenclature:: 0 (Biomarkers, Tumor)
Entry Date(s):: Date Created: 20210702 Date Completed: 20210726 Latest Revision: 20210726
Update Code:: 20240105
PubMed Central ID:: PMC8269195
DOI:: 10.3390/ijms22136771
PMID:: 34202474
: Czasopismo naukowe

Pełny tekst

Salivary gland tumors are a rare tumor entity within malignant tumors of all tissues. The most common are malignant mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma. Pleomorphic adenoma is the most recurrent form of benign salivary gland tumor. Due to their low incidence rates and complex histological patterns, they are difficult to diagnose accurately. Malignant tumors of the salivary glands are challenging in terms of differentiation because of their variability in histochemistry and translocations. Therefore, the primary goal of the study was to review the current literature to identify the recent developments in histochemical diagnostics and translocations for differentiating salivary gland tumors.

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja